Finucane Anne A. 4
4 · CVS HEALTH Corp · Filed Nov 21, 2025
Insider Transaction Report
Form 4
Finucane Anne A.
Director
Transactions
- Award
Deferred Stock Units
2025-11-20$76.04/sh+1,775.381$135,000→ 16,530.062 totalExercise: $0.00→ Common Stock (1,775.381 underlying) - Award
Common Stock
2025-11-20$76.04/sh+591$44,940→ 591 total
Footnotes (3)
- [F1]Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
- [F2]Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
- [F3]Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.